Price to Earning ratio Analysis of Scopus Biopharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PE
Period Ending - Dec-22
Very Poor PE
-0.0020
Period Ending - Dec-21
Very Poor PE
-0.0005
Growth
-266.48 %
Trailing Twelve Months PE
Period Ending - Dec-22
Very Poor PE
-0.730
PE Analysis of Scopus Biopharma Inc
| P/E Ratio -0.730 of Scopus Biopharma Inc is negative because of negative EPS. |
| PE Ratio of SCPS drastically fell by -266.48 % this year. |
| PE Ratio with value of -0.0005 was highest in Year Dec-21 in last Five Years. |
| PE Ratio with value of -0.0240 was lowest in Year Dec-18 in last Five Years. |
| Latest PE Ratio with value of -0.0020 is Greater than Average PE of -0.0068 in last five years. |
Other PE Related Info of SCPS that may interest you.
Scopus Biopharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| SCPS | 0.0011 | 6.0E-4 | 83.33 % | Biotechnology |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Earning of Scopus Biopharma Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|
| PE | -0.0020 | -0.0005 | -0.0014 | -0.0061 | -0.0240 | |
| Change | -266.48 % | 59.70 % | 77.90 % | 74.50 % | 0 % |
FY Chart of Price to Earning of Scopus Biopharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)